Latest Discovery Laboratories (DSCO) Headlines
Post# of 16
Posted On: 03/12/2014 8:22:12 PM
Latest Discovery Laboratories (DSCO) Headlines
Discovery Labs to Report 2013 Fourth Quarter Financial Results and Hold Conference Call on Thursday, March 13, 2014
PR Newswire - Tue Mar 11, 7:00AM CDT
Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, will report fourth quarter 2013 financial results on Thursday, March 13, 2014 before the open of the U.S. financial markets. The Company will host a conference call and live audio webcast at 10:00 a.m. Eastern Time that same day. During the conference call, Discovery Labs' management will discuss the 2013 fourth quarter financial results along with other business updates. A question-and-answer session will follow managements' remarks.
Discovery Laboratories (DSCO) Soars: Stock Rises 8.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 8:39AM CST
Discovery Laboratories Inc. was a big mover last session, as its shares rose nearly 9% on the day.
4 Biotech Stocks Under $10 to Watch
at The Street - Tue Feb 18, 1:30PM CST
Keep these under-$10 biotech stocks trading on unusual volume on your radar.
Traders Get Bullish on Shares of Discovery Laboratories, Shares Up 5.3% (DSCO)
Comtex SmarTrend(R) - Tue Feb 18, 11:42AM CST
Discovery Laboratories (NASDAQ
SCO) is one of today's best performing low-priced stocks, up 5.3% to $2.38 on 1.4x average daily volume. Discovery Laboratories has traded 725,000 shares thus far today, vs. average volume of 500,000 shares per day. The stock has outperformed the Dow (5.3% to the Dow's -0.0%) and outperformed the S&P 500 (5.3% to the S&P's 0.2%) during today's trading.
Caustic Soda: 2014 World Market Outlook and Forecast up to 2018
PR Newswire - Thu Feb 13, 12:49PM CST
Research and Markets
Research and Markets: China Synthetic Rubber Industry Report, 2013-2017
Business Wire - Thu Feb 13, 5:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/g798sf/china_synthetic) has announced the addition of the "China Synthetic Rubber Industry Report, 2013-2017" report to their offering.
4 Stocks Under $10 Making Big Moves
at The Street - Fri Jan 24, 6:00AM CST
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Market Technicals Simplified: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories
PR Newswire - Thu Jan 16, 6:33AM CST
Editor Note: For more information about this release, please scroll to bottom.
AAAResearchReports.com Pre-Market Technical Analysis: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories
PR Newswire - Tue Dec 17, 7:23AM CST
Editor Note: For more information about this release, please scroll to bottom.
Theravance (THRX) in Focus: Stock Adds 5.0% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 09, 6:30AM CST
Theravance Inc. (THRX) was a big mover last session, as the company saw its shares rise by a little over 5% on the day.
Discovery Laboratories Up 6.4%, Shares Break Through Resistance (DSCO)
Comtex SmarTrend(R) - Tue Nov 26, 11:44AM CST
Discovery Laboratories (NASDAQ SCO) is one of today's best performing low-priced stocks, up 6.4% to $2.33 on 1.1x average daily volume. Thus far today, Discovery Laboratories has traded 1.0 million shares, vs. average volume of 944,000 shares per day. The stock has outperformed the Dow (6.4% to the Dow's 0.2%) and outperformed the S&P 500 (6.4% to the S&P's 0.2%) during today's trading.
Discovery Labs to Present at the 25th Annual Piper Jaffray Health Care Conference
PR Newswire - Thu Nov 21, 6:45AM CST
Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced that management will present an overview and update on the Company's business at the 25th Annual Piper Jaffray Health Care Conference on Tuesday, December 3, 2013 at 1:10 PM ET. The conference will be held at the New York Palace Hotel in New York, New York.
Morning Research: Inovio Pharma Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc.
PR Newswire - Tue Nov 19, 8:03AM CST
Editor Note: For more information about this release, please scroll to bottom.
Discovery Labs Reports Third Quarter 2013 Financial Results
PR Newswire - Tue Nov 12, 3:50PM CST
Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced financial results for the third quarter ended September 30, 2013, as well as recent business updates. The Company will host a conference call Wednesday morning, November 13, 2013 at 10:00 AM ET. Conference call details are below.
Discovery Labs Receives FDA Clearance of IND to Initiate AEROSURF® Phase 2 Clinical Program
PR Newswire - Tue Nov 12, 3:05PM CST
Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's investigational new drug (IND) application for AEROSURF® and the Company can initiate its phase 2 clinical program.
Analyst sees future growth in Discovery Labs stock
By The Associated Press - AP - Mon Nov 11, 12:43PM CST
Shares of Discovery Laboratories Inc. climbed Monday after an analyst said the drug developer's shares do not reflect the full value of the company's opportunity with Surfaxin, a recently launched respiratory drug.
ZLCS, CLRX, DSCO and GALE added to NASDAQ Active Stock Watch List at GSR
ACCESSWIRE - Mon Nov 11, 9:19AM CST
New York, NY - (ACCESSWIRE) - 11/11/2013 - Growing Stock Report initiates its NASDAQ Active Stock Weekly Watch List adding Zalicus Inc. (NASDAQ:ZLCS), CollabRx, Inc. (NASDAQ:CLRX), Discovery Laboratories Inc. (NASDAQ SCO) and Galena Biopharma, Inc. (NASDAQ:GALE).
Discovery Labs to Host Conference Call to Discuss Third Quarter 2013 Results on Wednesday, November 13, 2013
PR Newswire - Fri Nov 08, 7:30AM CST
Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, will host a conference call at 10:00 a.m. ET on Wednesday, November 13, 2013 to discuss the third quarter financial results and other business updates. A question-and-answer session will follow managements' remarks. The Company will report third quarter 2013 results on Tuesday, November 12, 2013 after the close of the U.S. financial markets.
Discovery Labs to Report 2013 Fourth Quarter Financial Results and Hold Conference Call on Thursday, March 13, 2014
PR Newswire - Tue Mar 11, 7:00AM CDT
Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, will report fourth quarter 2013 financial results on Thursday, March 13, 2014 before the open of the U.S. financial markets. The Company will host a conference call and live audio webcast at 10:00 a.m. Eastern Time that same day. During the conference call, Discovery Labs' management will discuss the 2013 fourth quarter financial results along with other business updates. A question-and-answer session will follow managements' remarks.
Discovery Laboratories (DSCO) Soars: Stock Rises 8.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 8:39AM CST
Discovery Laboratories Inc. was a big mover last session, as its shares rose nearly 9% on the day.
4 Biotech Stocks Under $10 to Watch
at The Street - Tue Feb 18, 1:30PM CST
Keep these under-$10 biotech stocks trading on unusual volume on your radar.
Traders Get Bullish on Shares of Discovery Laboratories, Shares Up 5.3% (DSCO)
Comtex SmarTrend(R) - Tue Feb 18, 11:42AM CST
Discovery Laboratories (NASDAQ
SCO) is one of today's best performing low-priced stocks, up 5.3% to $2.38 on 1.4x average daily volume. Discovery Laboratories has traded 725,000 shares thus far today, vs. average volume of 500,000 shares per day. The stock has outperformed the Dow (5.3% to the Dow's -0.0%) and outperformed the S&P 500 (5.3% to the S&P's 0.2%) during today's trading. Caustic Soda: 2014 World Market Outlook and Forecast up to 2018
PR Newswire - Thu Feb 13, 12:49PM CST
Research and Markets
Research and Markets: China Synthetic Rubber Industry Report, 2013-2017
Business Wire - Thu Feb 13, 5:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/g798sf/china_synthetic) has announced the addition of the "China Synthetic Rubber Industry Report, 2013-2017" report to their offering.
4 Stocks Under $10 Making Big Moves
at The Street - Fri Jan 24, 6:00AM CST
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Market Technicals Simplified: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories
PR Newswire - Thu Jan 16, 6:33AM CST
Editor Note: For more information about this release, please scroll to bottom.
AAAResearchReports.com Pre-Market Technical Analysis: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories
PR Newswire - Tue Dec 17, 7:23AM CST
Editor Note: For more information about this release, please scroll to bottom.
Theravance (THRX) in Focus: Stock Adds 5.0% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 09, 6:30AM CST
Theravance Inc. (THRX) was a big mover last session, as the company saw its shares rise by a little over 5% on the day.
Discovery Laboratories Up 6.4%, Shares Break Through Resistance (DSCO)
Comtex SmarTrend(R) - Tue Nov 26, 11:44AM CST
Discovery Laboratories (NASDAQ
SCO) is one of today's best performing low-priced stocks, up 6.4% to $2.33 on 1.1x average daily volume. Thus far today, Discovery Laboratories has traded 1.0 million shares, vs. average volume of 944,000 shares per day. The stock has outperformed the Dow (6.4% to the Dow's 0.2%) and outperformed the S&P 500 (6.4% to the S&P's 0.2%) during today's trading. Discovery Labs to Present at the 25th Annual Piper Jaffray Health Care Conference
PR Newswire - Thu Nov 21, 6:45AM CST
Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced that management will present an overview and update on the Company's business at the 25th Annual Piper Jaffray Health Care Conference on Tuesday, December 3, 2013 at 1:10 PM ET. The conference will be held at the New York Palace Hotel in New York, New York.
Morning Research: Inovio Pharma Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc.
PR Newswire - Tue Nov 19, 8:03AM CST
Editor Note: For more information about this release, please scroll to bottom.
Discovery Labs Reports Third Quarter 2013 Financial Results
PR Newswire - Tue Nov 12, 3:50PM CST
Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced financial results for the third quarter ended September 30, 2013, as well as recent business updates. The Company will host a conference call Wednesday morning, November 13, 2013 at 10:00 AM ET. Conference call details are below.
Discovery Labs Receives FDA Clearance of IND to Initiate AEROSURF® Phase 2 Clinical Program
PR Newswire - Tue Nov 12, 3:05PM CST
Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's investigational new drug (IND) application for AEROSURF® and the Company can initiate its phase 2 clinical program.
Analyst sees future growth in Discovery Labs stock
By The Associated Press - AP - Mon Nov 11, 12:43PM CST
Shares of Discovery Laboratories Inc. climbed Monday after an analyst said the drug developer's shares do not reflect the full value of the company's opportunity with Surfaxin, a recently launched respiratory drug.
ZLCS, CLRX, DSCO and GALE added to NASDAQ Active Stock Watch List at GSR
ACCESSWIRE - Mon Nov 11, 9:19AM CST
New York, NY - (ACCESSWIRE) - 11/11/2013 - Growing Stock Report initiates its NASDAQ Active Stock Weekly Watch List adding Zalicus Inc. (NASDAQ:ZLCS), CollabRx, Inc. (NASDAQ:CLRX), Discovery Laboratories Inc. (NASDAQ
SCO) and Galena Biopharma, Inc. (NASDAQ:GALE). Discovery Labs to Host Conference Call to Discuss Third Quarter 2013 Results on Wednesday, November 13, 2013
PR Newswire - Fri Nov 08, 7:30AM CST
Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, will host a conference call at 10:00 a.m. ET on Wednesday, November 13, 2013 to discuss the third quarter financial results and other business updates. A question-and-answer session will follow managements' remarks. The Company will report third quarter 2013 results on Tuesday, November 12, 2013 after the close of the U.S. financial markets.
(0)
(0)